CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice
- aCenter for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
- bCenter for Research in Neuroscience, INSERM U1028, CNRS UMR 5292, 69675 Bron, France;
- cCenter for Brain Research, Medical University of Vienna, 1090 Vienna, Austria;
- dNational Reference Center for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalo-Universitaire de Montpellier, INSERM U1061, 34295 Montpellier, France;
- eDepartment of Immunology, Toulouse University Hospitals, 31059 Toulouse, France
See allHide authors and affiliations
Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved July 26, 2016 (received for review February 29, 2016)

Significance
Narcolepsy with cataplexy is a sleep disorder characterized by excessive daytime sleepiness and sudden loss of muscle tone. These clinical manifestations are the result of selective loss of a neuronal population producing orexin. The etiology of the disease remains elusive, although converging evidence points to a key involvement of the immune system. We developed an animal model to study the autoimmune processes at play in narcolepsy. We demonstrate that cytotoxic CD8 T cells, but not Th1 CD4 cells, are able to target and destroy orexinergic neurons. This selective neuronal loss is responsible for clinical signs mimicking human narcolepsy. By identifying potential immune effectors of the immunopathological process in narcolepsy, these findings offer a rationale for the use of immunotherapies.
Abstract
Narcolepsy with cataplexy is a rare and severe sleep disorder caused by the destruction of orexinergic neurons in the lateral hypothalamus. The genetic and environmental factors associated with narcolepsy, together with serologic data, collectively point to an autoimmune origin. The current animal models of narcolepsy, based on either disruption of the orexinergic neurotransmission or neurons, do not allow study of the potential autoimmune etiology. Here, we sought to generate a mouse model that allows deciphering of the immune mechanisms leading to orexin+ neuron loss and narcolepsy development. We generated mice expressing the hemagglutinin (HA) as a “neo-self-antigen” specifically in hypothalamic orexin+ neurons (called Orex-HA), which were transferred with effector neo-self-antigen–specific T cells to assess whether an autoimmune process could be at play in narcolepsy. Given the tight association of narcolepsy with the human leukocyte antigen (HLA) HLA-DQB1*06:02 allele, we first tested the pathogenic contribution of CD4 Th1 cells. Although these T cells readily infiltrated the hypothalamus and triggered local inflammation, they did not elicit the loss of orexin+ neurons or clinical manifestations of narcolepsy. In contrast, the transfer of cytotoxic CD8 T cells (CTLs) led to both T-cell infiltration and specific destruction of orexin+ neurons. This phenotype was further aggravated upon repeated injections of CTLs. In situ, CTLs interacted directly with MHC class I-expressing orexin+ neurons, resulting in cytolytic granule polarization toward neurons. Finally, drastic neuronal loss caused manifestations mimicking human narcolepsy, such as cataplexy and sleep attacks. This work demonstrates the potential role of CTLs as final effectors of the immunopathological process in narcolepsy.
Footnotes
- ↵1To whom correspondence should be addressed. Email: roland.liblau{at}inserm.fr.
Author contributions: R.B.-V., B.P., C.P., and R.S.L. designed research; R.B.-V., L.Y., C.Q., X.-H.N., S.A., M.R., A.C., A.-L.M., A.M., J.B., and C.P. performed research; R.B.-V., M.R., A.C., J.B., C.P., and R.S.L. analyzed data; and R.B.-V., L.Y., J.B., B.P., Y.D., C.P., and R.S.L. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1603325113/-/DCSupplemental.